These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33999892)

  • 41. Hypomagnesaemia and hypocalcaemia in a patient with systemic sclerosis: role of proton pump inhibitors.
    Perez MO; Neves EF; Bortolai CB; Sampaio-Barros PD; Andrade DC; Seguro LP
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-225-7. PubMed ID: 25068521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton pump inhibitors.
    Babb RR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1296-7; author reply 1297. PubMed ID: 17045214
    [No Abstract]   [Full Text] [Related]  

  • 43. Patient satisfaction with switching to esomeprazole from existing proton pump inhibitor therapy for gastro-oesophageal reflux disease: an observational, multicentre study.
    Hoogendoorn RJ; Groeneveld L; Kwee JA
    Clin Drug Investig; 2009; 29(12):803-10. PubMed ID: 19888786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amiodarone and optic neuropathy.
    Domingues MF; Barros H; Falcão-Reis FM
    Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):277-82. PubMed ID: 15115448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative Study on Effect of Rabeprazole Versus Omeprazole in Acid-peptic Disorder with Helicobacter pylori Infection.
    Gurung SB; Kc SR; Gyawali P; Amatya GL
    J Nepal Health Res Counc; 2020 Jan; 17(4):479-484. PubMed ID: 32001852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Speed of onset of oesophageal acid reduction with different proton-pump inhibitors in patients with reflux oesophagitis.
    Newton M; Burnham WR; Kamm MA
    Eur J Gastroenterol Hepatol; 1998 Sep; 10(9):753-8. PubMed ID: 9831269
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maintenance treatment with proton pump inhibitors for reflux esophagitis in pediatric patients: a systematic literature analysis.
    Illueca M; Wernersson B; Henderson C; Lundborg P
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):733-40. PubMed ID: 20808247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Is omeprazole helpful in the management of children with reflux oesophagitis?
    Varughese LA; Mazur LJ
    Arch Dis Child; 2002 Jul; 87(1):78-80. PubMed ID: 12089134
    [No Abstract]   [Full Text] [Related]  

  • 49. Spontaneous resolution of euthyroid optic neuropathy.
    Kitaguchi Y; Ishihara K; Nishida K
    Can J Ophthalmol; 2019 Aug; 54(4):e188-e192. PubMed ID: 31358166
    [No Abstract]   [Full Text] [Related]  

  • 50. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy?
    Takeuchi T; Oota K; Harada S; Edogawa S; Kojima Y; Sanomura M; Sakaguchi M; Hayashi K; Hongoh Y; Itabashi T; Kitae H; Hoshimoto M; Takeuchi N; Higuchi K
    Intern Med; 2015; 54(2):97-105. PubMed ID: 25742999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staying healthy while using PPIs. Be mindful of risks for fracture, low B12, and a spike in stomach acid.
    Harv Health Lett; 2015 Feb; 40(4):7. PubMed ID: 26223055
    [No Abstract]   [Full Text] [Related]  

  • 52. Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.
    Ziolkowski SL; Malabanan MH; Liebman SE
    Perit Dial Int; 2015; 35(5):586-7. PubMed ID: 26450478
    [No Abstract]   [Full Text] [Related]  

  • 53. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
    Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical assessment of optic nerve disorders.
    Riordan-Eva P
    Eye (Lond); 2004 Nov; 18(11):1161-8. PubMed ID: 15534601
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy and safety of proton-pump inhibitors in treating patients with non-erosive reflux disease: a network meta-analysis.
    Chen L; Chen Y; Li B
    Sci Rep; 2016 Sep; 6():32126. PubMed ID: 27581096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ipilimumab-associated bilateral optic neuropathy.
    Yeh OL; Francis CE
    J Neuroophthalmol; 2015 Jun; 35(2):144-7. PubMed ID: 25647225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
    Cundy T; Dissanayake A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity.
    Mandal S; Saxena R; Dhiman R; Mohan A; Padhy SK; Phuljhele S; Sharma P; Guleria R
    Br J Ophthalmol; 2021 Jul; 105(7):1024-1028. PubMed ID: 32713840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal Omeprazole Dosing and Symptom Control: A Randomized Controlled Trial (OSCAR Trial).
    Waghray A; Waghray N; Perzynski AT; Votruba M; Wolfe MM
    Dig Dis Sci; 2019 Jan; 64(1):158-166. PubMed ID: 30094626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.